Pfizer To Integrate Chai Discovery’s AI Platform To Advance And Scale Molecular Drug Design

Chai Discovery signs licensing deal with Pfizer to deploy AI models in drug discovery, enabling faster molecular design, improved antibody development, and broader biologics research capabilities. The post Pfizer To Integrate Chai Discovery’s AI Platform To Advance And Scale Molecular Drug Design appeared first on Metaverse Post.